2022January 06, 2014 -- /EPR NETWORK/ -- Renal Denervation (RDN) is a new catheter-based minimally invasive procedure that has shown exceptional reductions in blood pressure for patients with uncontrolled hypertension in multiple clinical trials. The procedure targetsoveractive renal sympathetic nerves disabling the brain-kidney crosstalk and thereby reducing the sympathetic drive as well as the blood pressure.Within the past four years, the science of renal sympathetic denervation has advanced at a very fast pace. Major industry players and innovative technologies have flooded the market place as the medical community is slowly starting to gain confidence in the therapy. With the treatment moving forward, there is a need for a comprehensive educational platform to increase awareness and knowledge about RDN. Renal Denervation is now being investigated in management of moderate Resistant Hypertension, congestive heart failure, diabetes, obstructive sleep apnea, arrhythmia and left ventricular hypertrophy.
Renaldenervationworld.org is a non-bias, dynamic digital platform envisioned to be the central location to educate and explore the evolution of RDN for both health care professionals and patients. Professional education spans across the basics of the sympathetic nervous system to the applications of the RDN beyond the treatment of hypertension bridging cardiologists, referring primary care physicians, interventionists, and nephrologists (hypertension specialist). Health care professionals can interact with the medical community by "submitting a case", reviewing the clinical trial archives, and querying the RDN experts. Patient education covers the basics of hypertension/resistant hypertension "what is renal denervation." and what to expect on the day of procedure. Patients can interact with other patients or read patients blogs. The education platform is edited with the guidance from international group of expert physicians including Nephrologist, Cardiologist, and Interventionalist.
